Risperidone: Clinical Trials

436 trials of Risperidone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

320 completed, 43 terminated, 43 unknown, 12 recruiting. 147 Phase 4, 106 Phase 3, 65 Phase 2, 55 Not applicable, 49 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 4147Completed 102, Terminated 18, Unknown 15, Recruiting 5, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1
Phase 3106Completed 87, Terminated 11, Unknown 3, Withdrawn 3, Recruiting 2
Phase 265Completed 49, Terminated 6, Withdrawn 4, Unknown 3, Recruiting 2, Active not recruiting 1
Not applicable55Completed 37, Unknown 10, Terminated 4, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 149Completed 41, Unknown 4, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 13Completed 1, Terminated 1, Unknown 1

Follow Risperidone: new trials by email Literature Review of Risperidone trials Research Report on Risperidone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risperidone vs Cariprazine in Acute Mania
Risperidone, Cariprazine - Bipolar 1 Disorder
Phase 4Not yet recruitingPakistan Institute of Medical Sciences502027-06-012026-06-24
Shortened LSD Intervention for Major Depressive Disorder
LSD, Risperidone - Major Depression Moderate, Major Depression Severe
Phase 1Not yet recruitingJohns Hopkins University102026-10-012026-09-22
Subjective Experience Following Psilocybin
Psilocybin high-dose, Psilocybin low-dose, Risperidone 1 MG - Investigating the Importance of the Subjective Psychedelic Experience
Phase 2RecruitingUniversity of Calgary1282026-05-152026-09-02
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Roluperidone, risperidone, aripiprazole - Negative Symptoms of Schizophrenia
Phase 3RecruitingMinerva Neurosciences3802026-04-232026-07-28
Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients
Cognitive Behavioral Therapy (CBT), risperidone - Schizophrenia Patients, Auditory Hallucination
Not applicableCompletedHasanuddin University502025-11-012026-04-17
Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia
Curcumin, Risperidone 4mg/day - Schizophrenia, Psychotic Disorders
Not applicableCompletedRinvil Renaldi442025-11-012026-04-14
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
risperidone, aripiprazole - Psychosis; Acute
Phase 4RecruitingNorthwell Health1202025-11-012026-05-26
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Psilocybin (Usona Institute), Risperidone 1 MG, MRI - Depression - Major Depressive Disorder, Anhedonia
Phase 1RecruitingMedical University of Vienna852025-11-012026-03-24
Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone
Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients, Neuroinflammation
Phase 2CompletedHasanuddin University802025-10-012026-05-12
Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients
Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients
Not applicableCompletedHasanuddin University802025-09-012026-04-23
the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period.
Spirulina Syrup, Placebo Syrup, Risperidone - Age 3 to 7 Years, Mild Autism Spectrum
Not applicableNot yet recruitingShahid Sadoughi University of Medical Sciences and Health Services822025-07-072025-07-11
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Psilocybin 25 mg, Risperidone 1 MG - Treatment Resistant Depression
Phase 2RecruitingCentre for Addiction and Mental Health122025-04-212026-10-19
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
LYN-005 (risperidone), Placebo for LYN-005, IR Risperidone - Schizophrenia, Schizoaffective Disorder
Phase 3WithdrawnLyndra Inc.2025-04-182025-04-08
A Pilot Study of Adjunctive Structured Supportive Psychotherapy in Schizophrenia
Structured supportive psychotherapy, Risperidone, Unstructured Supportive Conversation - Schizophrenia, Cognitive and Executive Dysfunction
Not applicableCompletedHasanuddin University442025-03-012026-06-30
Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia
Structured Supportive Psychotherapy, Risperidone 2 mg - Schizophrenia, Cognitive Dysfunction
Phase 2CompletedHasanuddin University462024-12-012026-03-17
Biomarkers to Enhance Early Schizophrenia Treatment
aripiprazole, risperidone, clozapine - Schizophenia Disorder
Phase 4RecruitingNorthwell Health1802024-09-042026-07-31
Magnetic Seizure Therapy for Psychotic Disorders
Magnetic seizure therapy by Magnetic stimulator, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc) - Psychotic Disorders
Not applicableRecruitingShanghai Jiao Tong University School of Medicine502024-09-012025-11-25
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Lumateperone 42 mg, Risperidone 2 mg - Apathy, Schizophrenia
Phase 3RecruitingLouisiana State University Health Sciences Center Shreveport802024-06-012024-07-01
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Aripiprazole, Risperidone - Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar602024-04-052025-11-25

Showing 20 of 436. Sign in to see all of them.

Conditions studied

Schizophrenia (247)  ·  Psychotic Disorders (106)  ·  Bipolar Disorder (40)  ·  Mental Disorders (18)  ·  Dementia (16)  ·  Autistic Disorder (14)  ·  Alzheimer Disease (13)  ·  Depression (12)  ·  Cocaine-Related Disorders (10)  ·  Mania (10)  ·  Anxiety Disorders (9)  ·  Aggression (8)  ·  Attention Deficit Disorder with Hyperactivity (8)  ·  Psychomotor Agitation (8)  ·  Metabolic Syndrome (7)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (32)  ·  Northwell Health (13)  ·  Janssen, LP (11)  ·  AstraZeneca (8)  ·  Janssen Pharmaceutica N.V., Belgium (8)  ·  Centre for Addiction and Mental Health (7)  ·  University of California, Los Angeles (7)  ·  Indivior Inc. (6)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (6)  ·  Washington University School of Medicine (6)  ·  H. Lundbeck A/S (5)  ·  Hasanuddin University (5)  ·  Janssen Korea, Ltd., Korea (5)  ·  Janssen Research & Development, LLC (5)  ·  National Institute of Mental Health (NIMH) (5)

Countries

United States (197)  ·  China (32)  ·  Canada (29)  ·  Germany (16)  ·  Spain (16)  ·  Taiwan (16)  ·  India (15)  ·  Russia (14)  ·  South Korea (13)  ·  France (10)  ·  Ukraine (10)  ·  Brazil (9)  ·  Bulgaria (9)  ·  Israel (9)  ·  Japan (9)

Top investigators

Benedicto Crespo-Facorro, Professor (3)

Results publications

PMID 37811711, PMID 25978742, PMID 26107752, PMID 36883881, PMID 37756123, PMID 38958149, PMID 40730715, PMID 40779812, PMID 41272239, PMID 10084637, PMID 10496251, PMID 11559786, PMID 11765093, PMID 12091192, PMID 12153826, PMID 12218423, PMID 12399139, PMID 12509667, PMID 12562742, PMID 12633121, PMID 12777271, PMID 12823075, PMID 12823080, PMID 14661862, PMID 14735295, PMID 15000267, PMID 15005752, PMID 15056517, PMID 15110730, PMID 15115949, PMID 15169694, PMID 15289699, PMID 15323593, PMID 15330403, PMID 15349007, PMID 15367925, PMID 15465989, PMID 15492353, PMID 15541061, PMID 15569893, PMID 15572276, PMID 15677618, PMID 15723025, PMID 15898966, PMID 15950022, PMID 15960566, PMID 16023735, PMID 16086617, PMID 16135859, PMID 16168792

NIH funding

2018 (2), N01MH090001 (2), N01MH90001 (2), P50MH066286 (2), R01MH037705 (2), R01MH060004 (2), 2004 (1), 2005 (1), 2008 (1), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2019 (1), K23MH074540 (1)